Detalhe da pesquisa
1.
Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
Gastroenterology
; 166(6): 1130-1144.e8, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262581
2.
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
Nature
; 574(7777): 268-272, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578521
3.
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer.
Cancer
; 130(S8): 1424-1434, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217532
4.
PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/ß-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis.
Hepatology
; 73(2): 644-660, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298475
5.
Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis.
Anticancer Drugs
; 33(1): e500-e506, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321420
6.
Post-hepatectomy liver failure prediction and prevention: Development of a nomogram containing postoperative anticoagulants as a risk factor.
Ann Hepatol
; 27(6): 100744, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964908
7.
Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
PLoS Biol
; 16(10): e2006483, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30335765
8.
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma.
Gut
; 69(4): 727-736, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519701
9.
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Gut
; 68(10): 1858-1871, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118247
10.
Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence.
Future Oncol
; 15(15): 1771-1780, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997850
11.
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
J Hepatol
; 69(5): 1057-1065, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030148
12.
Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Gastroenterology
; 153(3): 799-811.e33, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28583823
13.
Shp2 promotes liver cancer stem cell expansion by augmenting ß-catenin signaling and predicts chemotherapeutic response of patients.
Hepatology
; 65(5): 1566-1580, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28059452
14.
Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.
Carcinogenesis
; 38(2): 134-143, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742690
15.
Rubricella aquisinus gen. nov., sp. nov., a novel member of the family Rhodobacteraceae.
Antonie Van Leeuwenhoek
; 110(3): 331-337, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27853951
16.
LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Carcinogenesis
; 36(10): 1201-12, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26249360
17.
PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.
Mol Cancer
; 14: 193, 2015 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26576639
18.
Clinical significance of ribosome production factor 2 homolog in hepatocellular carcinoma.
Clin Res Hepatol Gastroenterol
; 48(3): 102289, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307254
19.
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
J Hepatol
; 59(3): 510-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665285
20.
A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.
BMC Cancer
; 13: 161, 2013 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23537217